Evidence map›Paper›PMID 42804478›Full record

ArticlePLoS computational biology2026

Attribution assignment for deep-generative sequence models enables interpretability analysis using positive-only data.

Robert Frank, Michael Widrich, Rahmad Akbar, Günter Klambauer, Geir Kjetil Sandve, Philippe A Robert, Victor Greiff

Abstract read
In one paragraph

Article in PLoS computational biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Robert FrankDepartment of Immunology and Oslo University Hospital, University of Oslo, Oslo, Norway.ORCID https://orcid.org/0000-0001-9097-7963
Michael WidrichInstitute for Machine Learning, Johannes Kepler University Linz, Linz, Austria.
Rahmad AkbarDepartment of Immunology and Oslo University Hospital, University of Oslo, Oslo, Norway.
Günter KlambauerInstitute for Machine Learning, Johannes Kepler University Linz, Linz, Austria.
Geir Kjetil SandveDepartment of Informatics, University of Oslo, Oslo, Norway.
Philippe A RobertDepartment of Immunology and Oslo University Hospital, University of Oslo, Oslo, Norway.
Victor GreiffDepartment of Immunology and Oslo University Hospital, University of Oslo, Oslo, Norway.ORCID https://orcid.org/0000-0003-2622-5032

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Generative machine learning models offer a powerful framework for therapeutic design, by efficiently exploring large spaces of biological sequences enriched for desirable properties. Unlike supervised learning methods, which require both positive and negative labeled data, generative models such as LSTMs can be trained solely on positively labeled sequences, for example, high-affinity antibodies. This is particularly advantageous in biological settings where negative data are scarce, unreliable, or biologically ill-defined. However, the lack of attribution methods for generative models has hindered the ability to extract interpretable biological insights from such models. To address this gap, we developed Generative Attribution Metric Analysis (GAMA), an attribution method for autoregressive generative models based on Integrated Gradients. We assessed GAMA using synthetic datasets with known ground truths to characterize its statistical behavior and validate its ability to recover biologically relevant features. We further demonstrated the utility of GAMA by applying it to experimental antibody-antigen binding data. GAMA enables model interpretability and the validation of generative sequence design strategies without the need for negative training data.

Indexed as

Computational BiologyDeep LearningMachine LearningAlgorithmsAnimalsAntibodiesGenerative Artificial IntelligenceHumansAntibodies

Identifiers

PMID42804478
PMCPMC13638040

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.